跳至主要内容
临床试验/JPRN-UMIN000024822
JPRN-UMIN000024822已完成未知

Effect of SGLT2 inhibitor on energy metabolism in patients with type 2 diabetes - Effect of SGLT2 inhibitor on energy metabolism in patients with type 2 diabetes

Kyoto University Graduate School of Medicine0 个研究点目标入组 100 人开始时间: 2017年1月1日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 80years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • Exclusion criteria are type 1 diabetes, secondary diabetes, severe ketosis, diabetic coma or pre-coma patients, alcoholism, severe depression or other psychological condition, malignancy, viral hepatitis, severe liver dysfunction, abnormal hemoglobinemia, severe infections diseases, pre- or post-surger, severe traumatic injury, contraindication for MRI like having metal pieces embedded in the body, pregnant or lactating woman, renal deficiency(eGFR<45mL/min/1.73m2), history of hypersensitivity to dapagliflozin, and those who are not considered to be suitable by an attending physician.

研究者

发起方
Kyoto University Graduate School of Medicine

相似试验

Effect of SGLT2 inhibitor on energy metabolism in... | 临床试验